Contact Us

Watch Our Webinar

Formulation and Analytical Considerations for Preclinical and Early Phase Pharmaceutical Development

About this Webinar

Join us for a comprehensive webinar delving into the critical aspects of formulation and analytical considerations in preclinical and early phase pharmaceutical development. In the early phases of clinical drug development, there are several factors that need to be balanced so that a robust data set can be generated while supporting a timely start to the FIH study when limited funding may be available.This webinar aims to equip researchers, scientists, and professionals working in start-up and small biotech companies with insights into effective strategies for early phase formulation and analysis. The goal is to facilitate phase-appropriate progress, enabling them to reach their next funding milestone successfully.In this session, our panel of experts will explore a range of topics including:

  • the selection of appropriate formulation strategies tailored to specific drug candidates
  • considerations for stability testing
  • the integration of analytical techniques for phase-appropriate characterization

Attendees will gain valuable insights into regulatory expectations and best practices for early phase pharmaceutical development, ensuring alignment with industry standards and facilitating seamless transition to later stages of drug development. Case studies and practical examples will be employed to illustrate how various approaches can be taken to facilitate small-molecule pharmaceutical development in a cost-constrained environment.

Fill out the form Below to Watch The Webinar